{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:54:26Z","timestamp":1788922466690,"version":"build-2803163510"},"reference-count":59,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["R17029NN"],"award-info":[{"award-number":["R17029NN"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignant mesothelioma (MM) still represents a devastating disease that is often detected too late, while the current effect of therapies on patient outcomes remains unsatisfactory. Invasiveness biomarkers may contribute to improving early diagnosis, prognosis, and treatment for patients, a task that could benefit from the development of high-throughput proteomics. To limit potential sources of bias when identifying such biomarkers, we conducted cross-species proteomic analyzes on three different MM sources. Data were collected firstly from two human MM cell lines, secondly from rat MM tumors of increasing invasiveness grown in immunocompetent rats and human MM tumors grown in immunodeficient mice, and thirdly from paraffin-embedded sections of patient MM tumors of the epithelioid and sarcomatoid subtypes. Our investigations identified three major invasiveness biomarkers common to the three tumor sources, CAPG, FABP4, and LAMB2, and an additional set of 25 candidate biomarkers shared by rat and patient tumors. Comparing the data to proteomic analyzes of preneoplastic and neoplastic rat mesothelial cell lines revealed the additional role of SBP1 in the carcinogenic process. These observations could provide new opportunities to identify highly vulnerable MM patients with poor survival outcomes, thereby improving the success of current and future therapeutic strategies.<\/jats:p>","DOI":"10.3390\/cancers12092430","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T08:05:18Z","timestamp":1598515518000},"page":"2430","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cross-Species Proteomics Identifies CAPG and SBP1 as Crucial Invasiveness Biomarkers in Rat and Human Malignant Mesothelioma"],"prefix":"10.3390","volume":"12","author":[{"given":"Jo\u00eblle S.","family":"Nader","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Nantes, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Boissard","sequence":"additional","affiliation":[{"name":"Universit\u00e9 d\u2019Angers, ICO Cancer Center, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Henry","sequence":"additional","affiliation":[{"name":"Universit\u00e9 d\u2019Angers, ICO Cancer Center, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Valo","sequence":"additional","affiliation":[{"name":"Universit\u00e9 d\u2019Angers, ICO Cancer Center, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Verri\u00e8le","sequence":"additional","affiliation":[{"name":"Universit\u00e9 d\u2019Angers, ICO Cancer Center, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gr\u00e9goire","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Nantes, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Coqueret","sequence":"additional","affiliation":[{"name":"Universit\u00e9 d\u2019Angers, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Guette","sequence":"additional","affiliation":[{"name":"Universit\u00e9 d\u2019Angers, ICO Cancer Center, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0820-3828","authenticated-orcid":false,"given":"Daniel L.","family":"Pouliquen","sequence":"additional","affiliation":[{"name":"Universit\u00e9 d\u2019Angers, Inserm, CRCINA, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3322\/caac.21572","article-title":"Mesothelioma: Scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jtho.2018.06.011","article-title":"Scientific advances and new frontiers in mesothelioma therapeutics","volume":"13","author":"Mutti","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ctrv.2015.05.001","article-title":"The established and future biomarkers of malignant pleural mesothelioma","volume":"41","author":"Panou","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16311","DOI":"10.18632\/oncotarget.24632","article-title":"Characterization of increasing stages of invasiveness identifies stromal\/cancer cell crosstalk in rat models of mesothelioma","volume":"9","author":"Nader","year":"2018","journal-title":"Oncotarget"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/cdd.2015.165","article-title":"Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease","volume":"23","author":"Chernova","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","article-title":"Guidelines for the welfare and use of animals in cancer research","volume":"102","author":"Workman","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2144\/000112598","article-title":"The costs of using unauthenticated, over-passaged cell lines: How much more data do we need?","volume":"43","author":"Hughes","year":"2007","journal-title":"Biotechniques"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-06-0436","article-title":"The use of targeted mouse models for preclinical testing of novel cancer therapeutics","volume":"12","author":"Olive","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.4161\/cbt.213","article-title":"Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: Better than commonly perceived-but they can be improved","volume":"2","author":"Kerbel","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bcp.2009.05.027","article-title":"Models for prevention and treatment of cancer: Problem vs. promises","volume":"78","author":"Aggarwal","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1900054","DOI":"10.1002\/prca.201900054","article-title":"Species-specific quantitative proteomics profiles of sarcoma patient-derived models closely reflect their primary tumors","volume":"13","author":"Shiozawa","year":"2019","journal-title":"Proteom. Clin. Appl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Mol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pouliquen, D.L., Boissard, A., Coqueret, O., and Guette, C. (2020). Biomarkers of tumor invasiveness in proteomics (Review). Int. J. Oncol.","DOI":"10.3892\/ijo.2020.5075"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"34664","DOI":"10.18632\/oncotarget.8970","article-title":"Characterization of preneoplastic and neoplastic rat mesothelial cell lines: The involvement of TETs, DNMTs, and 5-hydroxymethylcytosine","volume":"7","author":"Roulois","year":"2016","journal-title":"Oncotarget"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e000182","DOI":"10.1136\/jitc-2019-000182","article-title":"Involvement of the M-CSF\/IL-34\/CSF-1R pathway in malignant pleural mesothelioma","volume":"8","author":"Blondy","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jtho.2019.12.128","article-title":"Frequent homozygous deletions of type I interferon genes in pleural mesothelioma confer sensitivity to oncolytic measles virus","volume":"15","author":"Delaunay","year":"2020","journal-title":"J. Thor. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Nader, J.S., Guillon, J., Petit, C., Boissard, A., Franconi, F., Blandin, S., Lambot, S., Gr\u00e9goire, M., Verri\u00e8le, V., and Nawrocki-Raby, B. (2020). S100A4 is a biomarker of tumorigenesis, EMT, invasion, and colonization of host organs in experimental malignant mesothelioma. Cancers, 12.","DOI":"10.3390\/cancers12040939"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00432-010-0812-0","article-title":"Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis","volume":"136","author":"Xu","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jprot.2011.11.030","article-title":"Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma","volume":"75","author":"Morofuji","year":"2012","journal-title":"J. Proteom."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jprot.2012.10.004","article-title":"Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma","volume":"78","author":"Kimura","year":"2013","journal-title":"J. Proteom."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/379847","article-title":"Macrophage-capping protein CapG is a putative oncogene involved in migration and invasiveness in ovarian carcinoma","volume":"2014","author":"Glaser","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1134\/S0026893312030053","article-title":"Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE\/MS\/MS analysis","volume":"46","author":"Davalieva","year":"2012","journal-title":"Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.7150\/thno.22523","article-title":"CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription","volume":"8","author":"Huang","year":"2018","journal-title":"Theranostics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1007\/s13277-015-4585-6","article-title":"An integrated transcriptomic and computational analysis for biomarker identification in human glioma","volume":"37","author":"Xing","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_26","first-page":"1344","article-title":"Analysis of clinical characteristics of macrophage-capping protein (CAPG) gene expressed in glioma based on TCGA data and clinical experiments","volume":"18","author":"Fu","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1021\/pr400439m","article-title":"Laser microdissection and two-dimensional difference gel electrophoresis reveal the role of a novel macrophage-capping protein in lymph node metastasis in gastric cancer","volume":"12","author":"Ichikawa","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_28","first-page":"5549","article-title":"Function of the macrophage-capping protein in colorectal carcinoma","volume":"14","author":"Wu","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"djv360","DOI":"10.1093\/jnci\/djv360","article-title":"CAPG and GIPC1: Breast cancer biomarkers for bone metastasis development and treatment","volume":"108","author":"Westbrook","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mce.2017.02.002","article-title":"The peritumoural adipose tissue microenvironment and cancer. The roles of fatty acid binding protein 4 and fatty acid binding protein 5","volume":"462","author":"Guma","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MCO.0000000000000031","article-title":"Fatty acid binding proteins: Tissue-specific functions in health and disease","volume":"17","author":"Thumser","year":"2014","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mathis, C., Lascombe, I., Monnien, F., Bittard, H., Kleinclauss, F., Bedgedjian, I., Fauconnet, S., and Valmary-Degano, S. (2018). Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: Investigation with a long-term clinical follow-up. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-5137-4"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/cam4.1511","article-title":"FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma","volume":"7","author":"Zhong","year":"2018","journal-title":"Cancer Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/bjc.1997.37","article-title":"Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast","volume":"75","author":"Hewitt","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mustafa, D.A.M., Dekker, L.J., Stingl, C., Kremer, A., Stoop, M., Sillevis Smitt, P.A.E., Kros, J.M., and Luider, T.M. (2012). A proteome comparison between physiological angiogenesis and angiogenesis in glioblastoma. Mol. Cell. Proteom., 11.","DOI":"10.1074\/mcp.M111.008466"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4161\/cam.21831","article-title":"Laminins in basement membrane assembly","volume":"7","author":"Hohenester","year":"2013","journal-title":"Cell Adhes. Migr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lungcan.2019.07.011","article-title":"Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma","volume":"135","author":"Morra","year":"2019","journal-title":"Lung Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105700","DOI":"10.1016\/j.biocel.2020.105700","article-title":"Mechanism of miR-222 and miR-126 regulation and its role in asbestos-induced malignancy","volume":"121","author":"Gaetani","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0092-8674(00)81128-9","article-title":"Syntaxin 5 is a common component of the NSF-and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro","volume":"92","author":"Rabouille","year":"1998","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41556-019-0363-9","article-title":"IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma","volume":"21","author":"Kofuji","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cca.2013.09.048","article-title":"Annexin A5 as a potential marker in tumors","volume":"427","author":"Peng","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.placenta.2015.01.193","article-title":"Review: Annexin-A5 and cell membrane repair","volume":"36","author":"Bouter","year":"2015","journal-title":"Placenta"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3892\/ijo.2017.3942","article-title":"High annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma","volume":"50","author":"Tang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.3748\/wjg.v23.i39.7168","article-title":"Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance","volume":"23","author":"Sun","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopha.2016.09.086","article-title":"Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2\/p-ERK2\/c-Jun\/p-c-Jun(Ser73) and E-cadherin","volume":"84","author":"Sun","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41419-018-0685-8","article-title":"Annexin A5 regulates hepatocarcinoma malignancy via CRKI\/II-DOCK180-RAC1 integrin and MEK-ERK pathways","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/onc.2015.227","article-title":"Disruption of cytochrome c oxidase function induces Warburg effect and metabolic reprogramming","volume":"35","author":"Srinivasan","year":"2016","journal-title":"Oncogene"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/acscentsci.9b00266","article-title":"Neocarzilin A is a potent inhibitor of cancer cell motility targeting VAT-1 controlled pathways","volume":"5","author":"Gleissner","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12032-012-0396-4","article-title":"Effects of EHD2 interference on migration of esophageal squamous cell carcinoma","volume":"30","author":"Li","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10735-015-9614-7","article-title":"Decreased expression and prognostic role of EHD2 in human breast carcinoma with E-cadherin","volume":"46","author":"Shi","year":"2015","journal-title":"J. Mol. Histol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcmm.12403","article-title":"The role of the small GTPase Rab31 in cancer","volume":"19","author":"Chua","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1038\/sj.onc.1207683","article-title":"Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype","volume":"23","author":"Apostolou","year":"2014","journal-title":"Oncogene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1432-0436.2006.00121.x","article-title":"Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells","volume":"75","author":"Fernandes","year":"2007","journal-title":"Differentiation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.ajpath.2013.12.008","article-title":"Increasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesotheliomas tumors","volume":"184","author":"Rose","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Elhodaky, M., and Diamond, A.M. (2018). Selenium-binding protein 1 in human health and disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113437"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.3390\/nu7053938","article-title":"The subcellular location of selenoproteins and the impact on their function","volume":"7","author":"Diamond","year":"2015","journal-title":"Nutrients"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lee, Y.-M., Kim, S., Park, R.-Y., and Kim, Y.-S. (2020). Hepatitis B virus-X downregulates expression of selenium binding protein 1. Viruses, 12.","DOI":"10.3390\/v12050565"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12967-020-02211-4","article-title":"Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer","volume":"18","author":"Wang","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/JTO.0b013e31824c9272","article-title":"CCL2, Galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions","volume":"7","author":"Blanquart","year":"2012","journal-title":"J. Thorac. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/9\/2430\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:07:25Z","timestamp":1760177245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/9\/2430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["cancers12092430"],"URL":"https:\/\/doi.org\/10.3390\/cancers12092430","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]}}}